Kedzierska, 2003, Defective phagocytosis by human monocyte/macrophages following HIV-1 infection: underlying mechanisms and modulation by adjunctive cytokine therapy., J Clin Virol, 26, 247, 10.1016/S1386-6532(02)00123-3
Kedzierska, 2002, The role of monocytes and macrophages in the pathogenesis of HIV-1 infection., Curr Med Chem, 9, 1893, 10.2174/0929867023368935
Orenstein, 1997, Macrophages as a source of HIV during opportunistic infections., Science, 276, 1857, 10.1126/science.276.5320.1857
Zhu, 2002, HIV-1 in peripheral blood monocytes: an underrated viral source., J Antimicrob Chemother, 50, 309, 10.1093/jac/dkf143
Lewin, 1998, HIV-1 DNA and mRNA concentrations are similar in peripheral blood monocytes and alveolar macrophages in HIV-1-infected individuals., AIDS, 12, 719, 10.1097/00002030-199807000-00008
Sharova, 2005, Macrophages archive HIV-1 virions for dissemination in trans., EMBO J, 24, 2481, 10.1038/sj.emboj.7600707
Sonza, 1996, Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes., J Virol, 70, 3863, 10.1128/JVI.70.6.3863-3869.1996
Zhu, 2000, HIV-1 genotypes in peripheral blood monocytes., J Leukoc Biol, 68, 338, 10.1189/jlb.68.3.338
Zhu, 1993, Genotypic and phenotypic characterization of HIV-1 patients with primary infection., Science, 261, 1179, 10.1126/science.8356453
Naif, 1998, CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection., J Virol, 72, 830, 10.1128/JVI.72.1.830-836.1998
Rich, 1992, Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1)., J Clin Invest, 89, 176, 10.1172/JCI115559
Kalter, 1991, Enhanced HIV replication in macrophage colony-stimulating factor-treated monocytes., J Immunol, 146, 298, 10.4049/jimmunol.146.1.298
Koyanagi, 1988, Cytokines alter production of HIV-1 from primary mononuclear phagocytes., Science, 241, 1673, 10.1126/science.3047875
Schrier, 1993, Mechanisms of immune activation of human immunodeficiency virus in monocytes/macrophages., J Virol, 67, 5713, 10.1128/JVI.67.10.5713-5720.1993
Di Marzio, 1998, Chemokine receptor regulation and HIV type 1 tropism in monocyte-macrophages., AIDS Res Hum Retroviruses, 14, 129, 10.1089/aid.1998.14.129
Chiu, 2005, Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells., Nature, 435, 108, 10.1038/nature03493
Peng, 2006, Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity., J Exp Med, 203, 41, 10.1084/jem.20051512
Doehle, 2005, Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif., Virology, 339, 281, 10.1016/j.virol.2005.06.005
Rose, 2005, Regulated production and anti-HIV type 1 activities of cytidine deaminases APOBEC3B, 3F, and 3G., AIDS Res Hum Retroviruses, 21, 611, 10.1089/aid.2005.21.611
Ryan, 2004, Neuropsychiatric impact of hepatitis C on advanced HIV., Neurology, 62, 957, 10.1212/01.WNL.0000115177.74976.6C
Wiegand, 2004, A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins., EMBO J, 23, 2451, 10.1038/sj.emboj.7600246
Hariharan, 2005, Targets for human encoded microRNAs in HIV genes., Biochem Biophys Res Commun, 337, 1214, 10.1016/j.bbrc.2005.09.183
Huang, 2007, Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes., Nat Med, 13, 1241, 10.1038/nm1639
Hassan, 1986, Purification of human monocytes on gelatin-coated surfaces., J Immunol Methods, 95, 273, 10.1016/0022-1759(86)90415-1
Willey, 1988, In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity., J Virol, 62, 139, 10.1128/JVI.62.1.139-147.1988
